Ratings by Benchmark (Robert Wasserman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2023 | AbCellera Biologics | ABCL | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2023 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
4.42 (3.26) |
-26.24% | Details | |
| 8/25/2023 | Molekule Group, Inc. | MKUL | Downgrade | Hold (Buy) |
1.19 (0.21) |
-82.35% | Details | |
| 7/28/2023 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Intensity Therapeutics, Inc. | INTS | New Coverage | Speculative Buy (N/A) |
5.89 (4.30) |
-26.99% | Details | |
| 5/10/2023 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2023 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.59 (5.29) |
47.35% | Details | |
| 4/10/2023 | Emergent BioSolutions | EBS | Upgrade | Buy (Hold) |
10.56 (3.26) |
-69.13% | Details | |
| 3/28/2023 | Repligen | RGEN | New Coverage | Buy (N/A) |
160.25 (158.33) |
-1.2% | Details | |
| 3/21/2023 | Immunoprecise Antibodies Ltd. | IPA | Downgrade | Speculative Buy (Buy) |
3.08 (1.90) |
-38.31% | Details | |
| 3/16/2023 | Champions Oncology | CSBR | Downgrade | Hold (Buy) |
4.10 (5.89) |
43.66% | Details | |
| 2/14/2023 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 2/13/2023 | Proto Labs | PRLB | Upgrade | Buy (Hold) |
34.43 (25.76) |
-25.18% | Details | |
| 12/8/2022 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Speculative Buy (Buy) |
3.27 (3.40) |
3.98% | Details | |
| 11/10/2022 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
12.85 (3.26) |
-74.63% | Details | |
| 11/2/2022 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2022 | Thor Industries Inc. | THO | Downgrade | Hold (Buy) |
79.27 (92.43) |
16.6% | Details | |
| 10/24/2022 | Danaher | DHR | Downgrade | Hold (Buy) |
244.59 (245.46) |
0.36% | Details | |
| 8/18/2022 | AeroClean Thechnologies Inc. | AERC | Upgrade | Speculative Buy (Hold) |
4.34 (3.40) |
-21.66% | Details | |
| 7/15/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Hold (Buy) |
17.25 (4.34) |
-74.84% | Details | |
| 6/7/2022 | AeroClean Thechnologies Inc. | AERC | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/17/2022 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/9/2022 | Nephros | NEPH | Downgrade | Hold (Speculative Buy) |
2.21 (1.45) |
-34.39% | Details | |
| 2/22/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2022 | AeroClean Thechnologies Inc. | AERC | New Coverage | Speculative Buy (N/A) |
4.94 (17.25) |
249.19% | Details | |
| 1/20/2022 | Emergent BioSolutions | EBS | Upgrade | Buy (Neutral) |
45.59 (3.26) |
-92.85% | Details | |
| 12/21/2021 | AbCellera Biologics | ABCL | New Coverage | Buy (N/A) |
14.60 (4.74) |
-67.53% | Details | |
| 11/8/2021 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
52.61 (3.26) |
-93.8% | Details | |
| 10/29/2021 | Proto Labs | PRLB | Downgrade | Hold (Buy) |
58.64 (34.43) |
-41.29% | Details | |
| 10/25/2021 | Immunoprecise Antibodies Ltd. | IPA | New Coverage | Buy (N/A) |
6.19 (1.90) |
-69.31% | Details | |
| 9/22/2021 | Thermo Fisher Scientific | TMO | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2021 | Danaher | DHR | New Coverage | Buy (N/A) |
280.95 (245.46) |
-12.63% | Details | |
| 7/16/2021 | Thermo Fisher Scientific | TMO | New Coverage | Buy (N/A) |
514.48 (497.92) |
-3.22% | Details | |
| 5/25/2021 | Anebulo Pharmaceuticals | ANEB | New Coverage | Buy (N/A) |
8.00 (3.03) |
-62.13% | Details | |
| 5/14/2021 | BioLife Solutions | BLFS | Downgrade | Neutral (Buy) |
29.53 (14.17) |
-52.01% | Details | |
| 4/13/2021 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2021 | Emergent BioSolutions | EBS | New Coverage | Buy (N/A) |
79.25 (3.26) |
-95.89% | Details | |
| 3/23/2021 | BioLife Solutions | BLFS | Upgrade | Buy (Hold) |
38.57 (14.17) |
-63.26% | Details | |
| 1/21/2021 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | BioLife Solutions | BLFS | Downgrade | Hold (Buy) |
22.57 (14.17) |
-37.22% | Details | |
| 7/15/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
26.81 (38.93) |
45.21% | Details | |
| 5/14/2020 | Bio-Techne Corp. | TECH | New Coverage | Buy (N/A) |
261.83 (66.90) |
-74.45% | Details | |
| 5/14/2020 | Proto Labs | PRLB | New Coverage | Buy (N/A) |
96.62 (58.64) |
-39.31% | Details | |
| 5/14/2020 | Integer Holding | ITGR | New Coverage | Buy (N/A) |
70.64 (78.73) |
11.45% | Details | |
| 3/10/2020 | Codexis, Inc. | CDXS | New Coverage | Buy (N/A) |
11.43 (1.55) |
-86.44% | Details | |
| 2/19/2020 | BioLife Solutions | BLFS | New Coverage | (N/A) |
15.54 (14.17) |
-8.82% | Details | |
| 2/6/2020 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
92.19 (61.78) |
-32.99% | Details | |
| 11/18/2019 | Champions Oncology | CSBR | New Coverage | Speculative Buy (N/A) |
5.39 (5.89) |
9.28% | Details | |
| 10/24/2019 | Nephros | NEPH | New Coverage | Speculative Buy (N/A) |
9.61 (1.45) |
-84.91% | Details |
